Your browser doesn't support javascript.
loading
Healthcare utilisation and quality of life according to atrial fibrillation burden, episode frequency and duration.
Frausing, Maria Hee Jung Park; Van De Lande, Martijn; Linz, Dominik; Crijns, Harry J G M; Tieleman, Robert G; Hemels, Martin E W; De Melis, Mirko; Schotten, Ulrich; Kronborg, Mads Brix; Nielsen, Jens C; Van Gelder, Isabelle; Rienstra, Michiel.
  • Frausing MHJP; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark mariseje@rm.dk.
  • Van De Lande M; Department of Cardiology, Aarhus University Hospital, Aarhus N, Denmark.
  • Linz D; Department of Cardiology, University Medical Center Groningen, Groningen, The Netherlands.
  • Crijns HJGM; Cardiovascular Research Institute Maastricht (CARIM), Maastricht Universitair Medisch Centrum+, Maastricht, The Netherlands.
  • Tieleman RG; Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Hemels MEW; Cardiovascular Research Institute Maastricht (CARIM), Maastricht Universitair Medisch Centrum+, Maastricht, The Netherlands.
  • De Melis M; Department of Cardiology, Martini Hospital Groningen, Groningen, The Netherlands.
  • Schotten U; Department of Cardiology, Rijnstate Ziekenhuis Arnhem, Arnhem, The Netherlands.
  • Kronborg MB; Department of Cardiology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Nielsen JC; Cardiovascular Diagnostics, Medtronic Bakken Research Center, Maastricht, The Netherlands.
  • Van Gelder I; Department of Physiology, Maastricht University Medical Centre, Maastricht, The Netherlands.
  • Rienstra M; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Heart ; 110(16): 1030-1039, 2024 Jul 25.
Article en En | MEDLINE | ID: mdl-38944418
ABSTRACT

BACKGROUND:

We aimed to evaluate the association between atrial fibrillation (AF) burden, duration and number of episodes with healthcare utilisation and quality of life in patients with early paroxysmal AF without a history of AF.

METHODS:

In this observational cohort study, we included 417 patients with paroxysmal AF from the Reappraisal of Atrial Fibrillation interaction between hyperCoagulability, Electrical remodelling and Vascular destabilisation in the progression of AF (RACE V) Study. Patients were monitored with an insertable cardiac monitor for 1 year. Outcomes collected were healthcare utilisation, and quality of life assessed using the Atrial Fibrillation Severity Scale and EuroQol EQ-5D-5L questionnaires.

RESULTS:

During 1 year of follow-up, 63 973 AF episodes were detected in 353 (85%) patients. The median AF burden was 0.7% (IQR 0.1-4.0%). AF ablation was performed more frequently in patients with intermediate-to-high AF burdens (>0.2%) (16.2% vs 5.9%, p=0.01) and longer AF episode duration (>1 hour) (15.8% vs 2.0%, p=0.01), whereas cardioversions were more frequent in patients with longer episode duration (>1 hour) (9.5% vs 0%, p=0.04) and intermediate (0.2-1.9%) (but not high) AF burdens (13.6% vs 4.2%, p=0.01). Patients with many episodes (>147) reported higher symptom severity (p=0.001). No differences in symptom severity nor in EQ-5D-5L scores according to AF burden or duration were observed.

CONCLUSION:

In patients with early paroxysmal AF, higher AF burden and longer episode duration were associated with increased rates of healthcare utilisation but not with symptoms and quality of life. Patients with a higher number of episodes experienced more severe symptoms. TRIAL REGISTRATION NUMBER NCT02726698.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Calidad de Vida / Fibrilación Atrial Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Calidad de Vida / Fibrilación Atrial Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2024 Tipo del documento: Article